Advertisement

Topics

LuxCath LLC Company Profile

01:30 EST 15th December 2018 | BioPortfolio

LuxCath is a leader in catheter-based, real-time, optical tissue-electrode contact assessment, lesion progression monitoring, and lesion visualization for cardiac ablation. LuxCath’s technology is applicable to all cardiac ablation and is focused on Atrial Fibrillation ablation as its initial target market. The company’s technology involves continuous optical tissue interrogation during ablation procedures and is protected with issued patents as well as a portfolio of intellectual property filings. LuxCath’s technology continuously assesses tissue contact during ablation. It monitors tissue ablation under the surface of the heart in real time to help ensure the elimination of gaps of viable tissue between the lesions during ablation procedures. LuxCath aims to increase the value of healthcare by improving clinical outcomes while reducing procedure times, fluoroscopy exposure, arrhythmia recurrences, and costs. LuxCath was formed in partnership with researchers and faculty at the George Washington University, as well as the product development team at Nocturnal Product Development. More information about LuxCath can be found on the web at www.luxcath.com, or by calling +1-617-419-1800.


News Articles [3 Associated News Articles listed on BioPortfolio]

DATA: Starts & Stops: Zimmer Biomet/Apple Team-Up; Medtronic Announces Guardian Sensor Study

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial...   

DATA: Results Recap: Neovasc's Tiara TMVR Succeeds In 12 Patients

Results Recap is Medtech Insight's exclusive summary of clinical trial results that have been announced or published in the past...  

LuxCath Appoints Terry Ransbury as Chief Technology Officer

Company Also Announces Two Medtech Veteran Additions Rick Randall and John Fletcher to its Board of Directors LuxCath, LLC, a medical device company developing a novel cardiac...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

LuxCath LLC

LuxCath is a leader in catheter-based, real-time, optical tissue-electrode contact assessment, lesion progression monitoring, and lesion visualization for cardiac ablation. LuxCat...

LuxCath, LLC

LuxCath is a medical technology company founded to address persistent unmet needs in the catheter ablation treatment of cardiac arrhythmias. The company has developed breakthrough...

More Information about "LuxCath LLC" on BioPortfolio

We have published hundreds of LuxCath LLC news stories on BioPortfolio along with dozens of LuxCath LLC Clinical Trials and PubMed Articles about LuxCath LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LuxCath LLC Companies in our database. You can also find out about relevant LuxCath LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record